PatientsVille.com Logo

PatientsVille

Terbinafine Side Effects

Report Terbinafine Side Effects

If you experienced any harmful or unwanted effects of Terbinafine, please share your experience. This could help to raise awareness about Terbinafine side effects, identify uknown risks and inform health professionals and patients taking Terbinafine.

Examples: headache, dizziness


The most commonly reported Terbinafine side effects are:
Loss Of Taste (35 reports)
Anxiety (25 reports)
No Menstrual Periods (22 reports)
Still No Sign Of Imp (13 reports)
Diarrhea (11 reports)
Inability To Sleep Within 3 Days (10 reports)
Loss Of Taste Now 4 Weeks (10 reports)
Restless Sleep (7 reports)
Loss Of Taste Now 4 Weeks And Still No Sign Of Imp (6 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Terbinafine side effects . You can also compare Terbinafine side effects or view FDA reports.

Terbinafine Side Effects reported to FDA

The following Terbinafine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Terbinafine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 42 

Renal Failure, Hepatic Failure, Nikolsky^s Sign, Blister
on Jan 13, 2014 Male from FR , 25 years of age, was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: renal failure, hepatic failure, nikolsky^s sign, blister. Terbinafine dosage: N/A. Patient was hospitalized.

Excoriation, Erythema, Dry Skin
Patient was taking Terbinafine. Patient felt the following Terbinafine side effects: excoriation, erythema, dry skin on Jan 13, 2014 from GB Additional patient health information: Female , 88 years of age, was diagnosed with and. Terbinafine dosage: 250 Milligram Daily;.
Multiple prescriptions taken:
  • Paracetamol (4 Gram Daily; 1g Qds Prn)
  • Diprobase (3 Dosage Forms Daily;)
  • E45 (2 Dosage Forms Daily;)
  • Miconazole (3 Dosage Forms Daily;)
  • Permethrin (2 Dosage Forms Daily;)
  • Metformin (1000 Milligram Daily; Form Of Admin: Oral Powder)
  • Simvastatin (40 Milligram Daily; 40mg On)
  • Aspirin (75 Milligram Daily;)
Patient was hospitalized.

Respiratory Failure, Renal Failure Acute, Atrial Fibrillation, Groin Pain, Orchitis, Dermatitis Exfoliative, Thrombocytopenia, Hepatic Function Abnormal
Adverse event was reported on Jan 09, 2014 by a Male taking Terbinafine (Dosage: 250 Mg, Unk) was diagnosed with and. Location: GB , 57 years of age, weighting 198.4 lb, After Terbinafine was administered, patient encountered several Terbinafine side effects: respiratory failure, renal failure acute, atrial fibrillation, groin pain, orchitis, dermatitis exfoliative, thrombocytopenia, hepatic function abnormal.
Multiple concurrent drugs taken:

Hepatitis
on Jan 02, 2014 Male from GB , 45 years of age, was diagnosed with and was treated with Terbinafine (terbinafine). Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: hepatitis. Terbinafine (terbinafine) dosage: N/A.
Associated medications used:


Renal Failure Acute, Hepatic Function Abnormal, Dermatitis Exfoliative, Groin Pain, Respiratory Failure, Thrombocytopenia, Orchitis, Atrial Fibrillation
on Jan 07, 2014 Male from GB , 57 years of age, weighting 198.4 lb, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: renal failure acute, hepatic function abnormal, dermatitis exfoliative, groin pain, respiratory failure, thrombocytopenia, orchitis, atrial fibrillation. Terbinafine dosage: N/A.
Multiple prescriptions taken:

Menorrhagia
Patient was taking Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: menorrhagia on Dec 27, 2013 from NL Additional patient health information: Female , 33 years of age, weighting 154.3 lb, was diagnosed with and. Terbinafine dosage: 1 Keer Per Dag 1 Stuk(s).

Blood Bilirubin Increased, Hepatitis, Pruritus
Adverse event was reported on Dec 26, 2013 by a Male taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: GB , 45 years of age, Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: blood bilirubin increased, hepatitis, pruritus.
Associated medications used:

Pythium Insidiosum Infection
on Dec 20, 2013 Female from US , 14 years of age, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: pythium insidiosum infection. Terbinafine dosage: N/A.
Multiple prescriptions taken:
  • Voriconazole
  • Amphotericin B
  • Micafungin
  • Posaconazole
  • Deferoxamine


Rash, Staphylococcal Infection, Bacteraemia, Sepsis
on Dec 05, 2013 Male from US , 74 years of age, was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: rash, staphylococcal infection, bacteraemia, sepsis. Terbinafine dosage: 250 Mg, Od + Oral. Patient was hospitalized.

Pancreatitis, Liver Function Test Abnormal
Patient was taking Terbinafine (no Pref. Name) 250 Mg. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: pancreatitis, liver function test abnormal on Dec 05, 2013 from COUNTRY NOT SPECIFIED Additional patient health information: Male , 66 years of age, weighting 121.3 lb, was diagnosed with and. Terbinafine (no Pref. Name) 250 Mg dosage: N/A.
Associated medications used: Patient was hospitalized.

Jaundice Cholestatic
Adverse event was reported on Dec 05, 2013 by a Female taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: US , 82 years of age, weighting 124.1 lb, Patient felt the following Terbinafine side effects: jaundice cholestatic.
Multiple prescriptions taken:
  • Co-amoxiclav
  • Bisoprolol
  • Brinzolamide
  • Digoxin
  • Codamol (codeine And Paracetamol)
  • Furosemide
  • Lansoprazole
  • Latanoprost
Patient was hospitalized.

Pancreatitis, Gastrointestinal Inflammation, Liver Function Test Abnormal
on Dec 20, 2013 Male from GB , 66 years of age, weighting 121.3 lb, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: pancreatitis, gastrointestinal inflammation, liver function test abnormal. Terbinafine dosage: N/A.
Multiple concurrent drugs taken: Patient was hospitalized.

Staphylococcal Infection, Bacteraemia, Sepsis
on Dec 20, 2013 Male from GB , 74 years of age, was treated with Terbinafine (terbinafine). Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: staphylococcal infection, bacteraemia, sepsis. Terbinafine (terbinafine) dosage: 250 Mg (250 Mg, 1 In 1 D), Oral.
Associated medications used:
  • Aspirin (acetylsalicylic Acid)
  • Budesonide
  • Calceos (lekovit Ca)
  • Co-codamol(panadeine Co)
  • Flucloxacillin(flucloxacillin)
  • Latanoprost
  • Omeprazole(omeprazole)
  • Peppermint Oil(mentha X Piperita Oil)
Patient was hospitalized.

Venous Thrombosis Limb
Patient was taking Terbinafine. Patient felt the following Terbinafine side effects: venous thrombosis limb on Nov 25, 2013 from DE Additional patient health information: Male , 78 years of age, was diagnosed with and. Terbinafine dosage: 250 Mg (250 Mg, 1 In 1 D), Oral.
Multiple prescriptions taken:

Pancreatitis, Liver Function Test Abnormal, Gastrointestinal Inflammation, Cholelithiasis
Adverse event was reported on Mar 04, 2014 by a Male taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: GB , 66 years of age, weighting 121.3 lb, After Terbinafine was administered, patient encountered several Terbinafine side effects: pancreatitis, liver function test abnormal, gastrointestinal inflammation, cholelithiasis.
Multiple concurrent drugs taken: Patient was hospitalized.

Staphylococcal Sepsis, Staphylococcal Bacteraemia
on Dec 12, 2013 Male from GB , 74 years of age, was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: staphylococcal sepsis, staphylococcal bacteraemia. Terbinafine dosage: N/A.
Associated medications used:
  • Aspirin
  • Budesonide
  • Calceos
  • Co-codamol
  • Flucloxacillin
  • Latanoprost
  • Omeprazole
  • Peppermint Oil
Patient was hospitalized.

Haematochezia, Rectal Haemorrhage
on Nov 22, 2013 Female from GB , 41 years of age, weighting 169.8 lb, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: haematochezia, rectal haemorrhage. Terbinafine dosage: N/A.
Multiple prescriptions taken:

Muscular Weakness, Fall, Cerebellar Syndrome
Patient was taking Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: muscular weakness, fall, cerebellar syndrome on Nov 15, 2013 from FR Additional patient health information: Male , 88 years of age, was diagnosed with and. Terbinafine dosage: Unk Ukn, Qd.
Multiple concurrent drugs taken: Patient was hospitalized.

Renal Neoplasm, Vaginal Haemorrhage
Adverse event was reported on Dec 31, 2013 by a Female taking Terbinafine (Dosage: 250mg (250mg, 1 In 1 D) Oral) . Location: US , 57 years of age, weighting 135.0 lb, Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: renal neoplasm, vaginal haemorrhage.
Associated medications used:
  • Premarin (Vaginal)
  • Baby Aspirin (acetylsalicylic Acid)
  • Vitamin D (ergocalciferol)
  • Calcium (calcium)
  • Co-q-10 (ubidecarenone)
  • Omega 3 (fish Oil)


Stevens-johnson Syndrome, Glossodynia, Eczema, Insomnia, Stress
on Jan 20, 2014 Male from GB , 78 years of age, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: stevens-johnson syndrome, glossodynia, eczema, insomnia, stress. Terbinafine dosage: N/A.

Metrorrhagia
on Nov 07, 2013 Female from NL , 23 years of age, weighting 152.1 lb, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: metrorrhagia. Terbinafine dosage: 1 Keer Per Dag 1 Stuk(s).
Multiple concurrent drugs taken:

Bile Duct Cancer
Patient was taking Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: bile duct cancer on Nov 06, 2013 from US Additional patient health information: Female , 56 years of age, weighting 188.0 lb, was diagnosed with and. Terbinafine dosage: 250 Mg 1 Tablet Daily By Mouth.
Associated medications used:
  • Symbicort
  • Nasonex
  • Lorazepam
  • Senna
  • Zrytec
  • Docusate Sodium
Patient was hospitalized and became disabled.

Dyspnoea, Asthma
Adverse event was reported on Nov 05, 2013 by a Female taking Terbinafine (Dosage: 1 Keer Per Dag 1 Stuk(s)) . Location: NL , 52 years of age, weighting 211.6 lb, Patient felt the following Terbinafine side effects: dyspnoea, asthma.
Multiple prescriptions taken:

Lichen Planus
on Nov 03, 2013 Male from NL , 29 years of age, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: lichen planus. Terbinafine dosage: Gebruik Niet Bekend.

Rhabdomyolysis, Pain In Extremity, Blood Creatine Phosphokinase Increased
on Nov 07, 2013 Male from GB , 29 years of age, was diagnosed with and was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: rhabdomyolysis, pain in extremity, blood creatine phosphokinase increased. Terbinafine dosage: N/A. Patient was hospitalized and became disabled.

Page 1 of 42 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Terbinafine

Find Out How to Take Terbinafine

Discuss Terbinafine Side Effects

Did You Have a Terbinafine Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Terbinafine for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

Alternative TERBINAFINE Names:TERBINAFI

Active Ingredient: TERBINAFI

More About Terbinafine

Side Effects reported to FDA: 1036

Terbinafine safety alerts: 2001 2000

Reported deaths: 23

Reported hospitalizations: 126

Lamisil (terbinafine hydrochloride)

Sporanox (itraconazole)

Audience: Dermatologists and other healthcare professionals

FDA is issuing a public health advisory concerning Sporanox and Lamisil, systemic drug therapies to treat onychomycosis (fungal nail infections). Healthcare professionals are notified of the possible association of serious cardiac adverse events with the administration of Sporanox and hepatic adverse events with the administration of both Sporanox and Lamisil. New labeling for both Sporanox and Lamisil recommends that healthcare providers obtain nail specimens for laboratory testing prior to prescribing the medications for onychomycosis to confirm the diagnosis. FDA's concerns do NOT apply to the over-the-counter versions of Lamisil, which are topical creams.

[May 11, 2001 - Letter - Novartis Pharmaceuticals Corp.]
[May 09, 2001 - Letter - Janssen Pharmaceutica Products, L.P.]
[May 09, 2001 - Public Health Advisory - FDA]
[May 09, 2001 - Questions and Answers - FDA]
[May 09, 2001 - Revised Sporanox Capsules Label - Janssen Pharmaceutica Products, L.P.]

 

Latest Terbinafine clinical trials